Waracharee Srifa

Stanford University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index1.0kcitations16works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(10), Virus-based gene therapy research(6), Hemoglobinopathies and Related Disorders(4), CAR-T cell therapy research(4), Mesenchymal stem cell research(3)

Publications16 total

Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease
Science Translational Medicine·2021· 150 citedOpen Access
Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells
Nature Medicine·2021· 80 citedOpen Access
Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing
Molecular Therapy·2021· 40 citedOpen Access
Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells
2020· 3 citedOpen Access
Metabolic engineering generates a transgene-free safety switch for cell therapy
Nature Biotechnology·2020· 51 cited
Macrophage Subpopulation Dynamics Shift following Intravenous Infusion of Mesenchymal Stromal Cells
Molecular Therapy·2020· 24 citedOpen Access
Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
Nature Communications·2020· 77 citedOpen Access
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
Nature Communications·2019· 30 citedOpen Access
Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
Nucleic Acids Research·2019· 149 citedOpen Access
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
Nature Communications·2019· 29 citedOpen Access
Gene correction for SCID-X1 in long-term hematopoietic stem cells
Nature Communications·2019· 189 citedOpen Access
Gene Correction for SCID-X1 in Long-Term Hematopoietic Stem Cells
2018· 5 citedOpen Access
Rapid Phenotypic and Genotypic Diversification After Exposure to the Oral Host Niche in <i>Candida albicans</i>
Genetics·2018· 104 citedOpen Access
Exposure to the oral host niche yields rapid phenotypic and genotypic diversification in <i>Candida albicans</i>
2018Open Access
Abstract 100: Human Mesenchymal Stromal Cells Engineered to Overexpress PDGF-B Using CRISPR/Cas9/rAAV6-based Tools Improve Wound Healing
Plastic & Reconstructive Surgery Global Open·2017· 10 citedOpen Access
Precise Correction of Disease Mutations in Induced Pluripotent Stem Cells Derived From Patients With Limb Girdle Muscular Dystrophy
Molecular Therapy·2016· 86 citedOpen Access

Frequent Co-authors

Matthew H. Porteus(13), Ciaran M. Lee(7), Gang Bao(7), Sruthi Mantri(6), Volker Wiebking(5), Maria Grazia Roncarolo(5), Joab Camarena(5), Mara Pavel-Dinu(4), Beruh Dejene(4), Carmencita E. Nicolas(4), Eric Kildebeck(4), Niraj Punjya(4), Camille Sindhu(4), Matthew A. Inlay(4), Suk See De Ravin(4), Harry L. Malech(4), Kenneth I. Weinberg(4), Daniel P. Dever(4), Nivedita Saxena(3), Christopher A. Vakulskas(3)